Gabriela Lavezzari, PhD, MBA joined the Duke-Robert J. Margolis Center for Health Policy in March 2016. Dr. Lavezzari leads a portfolio of projects aimed at evaluating, creating and implementing new evidence-based policies that shift the current paradigm from fee-for-service (FFS) to value-based reimbursement for innovative medical products. Her primary areas of research interest include medical products payment reform, value-based reimbursement, and economic incentives for antimicrobial medical products.
Previously, Dr. Lavezzari was the Assistant Vice President, Scientific Affairs & Regulatory Affairs at Pharmaceutical Research and Manufacturers of American (PhRMA) where she was the primary staff lead for a variety of strategic initiatives aimed at establishing PhRMA as a valuable source of scientific expertise in innovative biopharmaceutical research and development within the Scientific & Regulatory Affairs (S&RA) division of PhRMA.
Prior to joining PhRMA, Dr. Lavezzari served as Director Extramural Development at the Medco Research Institute, a subsidiary of Medco Health Solutions, where she led clinical utility and cost-effectiveness research to create value-based reimbursement decisions in a variety of different therapeutic areas. Prior to Medco, Dr. Lavezzari spent few years at Theranostics Health, a proteomic-based diagnostics company where she led the laboratory operations and the oncology product development. Prior to Theranostics, Dr. Lavezzari worked at Social Scientific Systems where she provided scientific support to and managed multiple ACTG, laboratory science, laboratory technical and specialty laboratory committees, subcommittees and working groups.
In addition to her experience in the industry, Dr. Lavezzari spent almost six years in research at the National Institutes of Health (NIH) and at Georgetown University, where she completed her post-doctoral training.
Health policy, advocacy, reimbursement, pharmaceutical regulatory affairs, business development.
Dr. Lavezzari earned her PhD in Biological Sciences from University of Milano (Italy), and her MBA from the New York Institute of Technology (NYIT, NY).